Generic User Fees Would Create 10-Month ANDA Review Time
This article was originally published in The Pink Sheet Daily
Executive Summary
Annual revenue of $250 million to $300 million in generic drug user fees is discussed as FDA unveils its "four walls and a roof" guiding principles.